openPR Logo
Press release

Hepatitis Marker Testing Market Extensive Growth Opportunities to be Witnessed by 2021

05-31-2017 04:57 PM CET | Health & Medicine

Press release from: Persistence Market Research

Hepatitis Marker Testing Market Extensive Growth

The liver is an essential organ of the body which helps in digestion of food, removal of toxins from the blood, and storage of energy in the body. Inflammation of the liver usually due to viral infections, excessive alcohol consumption, and drugs can cause hepatitis. Hepatitis can be classified as hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E through laboratory testing. Acute infection may occur with no symptoms or limited symptoms such as jaundice, dark urine, nausea, extreme fatigue, vomiting, and abdominal pain. Hepatitis A is causes abdominal pain, jaundice, fever, nausea, and fatigue. The symptoms of hepatitis B include mild fever, diarrhea, muscle ache, skin rashes, and headache. Hepatitis C is a contagious liver disease that greatly damages the liver.

To get the view of full report @ http://www.persistencemarketresearch.com/market-research/hepatitis-marker-testing-market.asp

Hepatitis B and C are most commonly cause of liver cancer, and cirrhosis. Hepatitis A and E are mainly caused by the ingestion of contaminated food. Hepatitis B, C, and D spread when a healthy person comes in contact with the bodily fluids of an infected person, receipt of contaminated blood or blood products, invasive medical procedure using contaminated equipment and by sexual contact. People suffering from hepatitis are tested with a range of markers depending on the symptoms exhibited, clinical history, and other tests. For instance, hepatitis B surface antigen is the vital marker for the screening and diagnosis of the hepatitis B virus. Similarly, anti-HAV IgM is a marker for the diagnosis of the hepatitis A virus.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4085

Chronic hepatitis is diagnosed through liver biopsy and blood tests. According to the World Health Organization (WHO), globally, 130 million to 150 million people suffer from chronic hepatitis C. Furthermore, globally, every year about 20 million and 1.4 million people are infected by hepatitis E and A respectively. WHO initiates various hepatitis awareness programs to reduce the transmission of agents that cause viral hepatitis, and, in turn, reduce the morbidity and mortality rates of the disease.

North America dominates the global market for hepatitis marker testing due to rising incidence of hepatitis in the region. The global hepatitis marker testing market in Asia is expected to expand significantly in the next five years. China and India are expected to be the fastest growing hepatitis marker testing markets in the Asia-Pacific region. The key driving forces for the hepatitis marker testing market in developing countries include a large pool of patients, increasing awareness programs about the disease, and rising government funding.

Increase in healthcare expenditure, changing lifestyles, and increasing initiatives by various governments are some of the key factors driving the growth of the global hepatitis marker testing market. Moreover, increasing healthcare awareness is also fuelling the growth of this market. However, complex regulatory frameworks are one of the major factors restraining the growth of this market.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/4085

Some of the trends in the global hepatitis marker testing market are rise in awareness programs by the World Health Organization (WHO). Some of the major companies operating in the global hepatitis marker testing market are Becton, Dickinson and Company, Beckman Coulter, Inc., Cepheid, bioMérieux, Bio-Rad Laboratories, Inc., Siemens Healthcare, QIAGEN, F. Hoffmann La–Roche Ltd, Hologic, Inc., and Thermo Fisher Scientific, Inc.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatitis Marker Testing Market Extensive Growth Opportunities to be Witnessed by 2021 here

News-ID: 558218 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Hepatitis

Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each